ARTICLE SYNOPSIS...When Jim Cramer on "CNBC Squawk on the Street" says that he likes a stock, is it worth looking at?
ARTICLE SYNOPSIS...One of the worst performing sectors this past year has been the Health Care sector, and of its sub-sectors, Biotechnology was one of the poorest performers. Gilead Sciences (GILD), a component of that sub-sector lost about 21% over the past year, making
ARTICLE SYNOPSIS...Gilead Sciences, Inc. (GILD) President and COO John Milligan sold 100,000 shares for $10.3 million on September 8, 2015. What does that suggest?
ARTICLE SYNOPSIS...A share to keep an eye on, but is it due for a correction?
ARTICLE SYNOPSIS...Shares of Gilead Sciences, Inc. have been in a long-term bull market for several years, but warnings of a bearish trend reversal are now in place.